177 VISCERAL ADIPOSE TISSUE INFLUENCES ANTI-TUMOR NECROSIS FACTOR (TNF) TREATMENT RESPONSE IN IBD

Phillip Gu; Avneesh Chhabra; Punya Chittajallu; Christopher J Chang; Denisse Mendez; Andrew J. Gilman; David Fudman; Xi Yin; Linda A. Feagins

doi:10.1016/s0016-5085(21)00848-9

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

226 VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS (TNF) THERAPY

Phillip Gu, Avneesh Chhabra, Punya Chittajallu, Christopher J Chang, Denisse Mendez, Andrew J. Gilman, David Fudman, Xi Yin, Linda A. Feagins

Article2009

The association of tumor necrosis factor α receptor 2 and tumor necrosis factor α with insulin resistance and the influence of adipose tissue biomarkers in humans

Marie‐France Hivert, Lisa Sullivan, Peter Shrader, Caroline S. Fox, David M. Nathan, Ralph B. D’Agostino, Peter W.F. Wilson, Emelia Benjamin, James B. Meigs

Article2001

The α and β Subunits of IκB Kinase (IKK) Mediate TRAF2-Dependent IKK Recruitment to Tumor Necrosis Factor (TNF) Receptor 1 in Response to TNF

Anne Devin, Yong Lin, Shoji Yamaoka, Zhiwei Li, Michael Karin, Zheng-gang Liu

Article2006

Anti‐TNF drugs in psoriasis and IBD ‐ Where are we going?

Richard B. Warren, Christopher Em Griffiths, James O. Lindsay

Letter2009

Graves’ Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy

Jae Il Shin, Min Jung Kim, Jae Seung Lee